657 |
Treatment supporter to TB Patient |
25/03/2022 |
|
658 |
Patient Management SMS |
25/03/2022 |
|
667 |
TB Awareness Generation in Community |
25/03/2022 |
|
668 |
Nutritional Counselling for TB Patients |
25/03/2022 |
|
567 |
Role of Health Volunteers in Community Engagement |
25/03/2022 |
|
568 |
Role of Health Volunteers in Community Mobilization |
25/03/2022 |
|
572 |
Strategies of Community Engagement in NTEP |
25/03/2022 |
|
520 |
Role of Health Volunteers |
25/03/2022 |
|
679 |
Treatment Supporter Honorarium Eligibility |
25/03/2022 |
|
569 |
Role of Health Volunteers in Digital Interventions |
25/03/2022 |
|
682 |
Wellness Activity for TB Patients |
25/03/2022 |
|
684 |
Psychosocial Support to TB Patients |
25/03/2022 |
|
59 |
Vulnerable Population for Tuberculosis |
25/03/2022 |
|
579 |
TB-HIV BURDEN |
26/03/2022 |
|
335 |
Host factors in TB |
26/03/2022 |
|
698 |
NTEP Objectives- in relation to NSP 2017-2025 |
26/03/2022 |
|
706 |
Registers & Documentation at TU level |
26/03/2022 |
|
717 |
TB-Tobacco Bidirectional Screening |
26/03/2022 |
|
715 |
TB-HIV Bidirectional Screening |
26/03/2022 |
|
716 |
TB-Diabetes Bidirectional Screening |
26/03/2022 |
|
718 |
TB-COVID Bidirectional Screening |
26/03/2022 |
|
729 |
Integrated DR-TB Algorithm |
26/03/2022 |
|
735 |
Pharmacological Basis of treatment |
26/03/2022 |
|
740 |
TB Treatment Card |
26/03/2022 |
|
741 |
NTEP TB ID Card |
26/03/2022 |
|
742 |
Transfer of TB Patient |
26/03/2022 |
|
745 |
Pharmacovigilance in NTEP |
26/03/2022 |
|
746 |
Follow up sputum examination |
26/03/2022 |
|
749 |
Prevention of Drug Resistance |
26/03/2022 |
|
766 |
Treatment Regimen for DSTB - Pediatrics |
26/03/2022 |
|